Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA

Overview of attention for article published in ACS Chemical Neuroscience, September 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 7 X users

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 5 X posts from 7 X users, with an upper bound of 4,833 followers.

Asking questions about SCRAs and their toxic nature... Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA https://t.co/6craOjsxc1

Papers like this make me miss working in the lab every time. Another great piece of work by a.o. @samuel_b_phd Do toxic synthetic cannabinoid receptor agonists have signature in vitro activity profiles? A case study of AMB-FUBINACA https://t.co/NVFHGT…

RT @ArrestinBot: Do toxic synthetic cannabinoid receptor agonists have signature in vitro activity profiles? A case study of AMB-FUBINACA.…

Do toxic synthetic cannabinoid receptor agonists have signature in vitro activity profiles? A case study of AMB-FUBINACA. https://t.co/aiPQpdcDbP ACS Chem Neurosci #GPCR #signaling #pharmacology

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.